Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
Trial Type: Lymphoma (Pediatric)
Randomized Phase 3 Trial of Nivolumab
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination with Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell
Status: Open
Trial Type:
Lymphoma (Pediatric)
Contact: Jennifer Welch, MD
jwelch@brownhealth.org